PubRank

Herman van Dekken

Author PubWeight™ 71.27‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 2002 8.72
2 TMPRSS2:ERG fusion by translocation or interstitial deletion is highly relevant in androgen-dependent prostate cancer, but is bypassed in late-stage androgen receptor-negative prostate cancer. Cancer Res 2006 2.83
3 Verification and unmasking of widely used human esophageal adenocarcinoma cell lines. J Natl Cancer Inst 2010 2.79
4 Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial. Ann Surg 2007 2.78
5 Long-term survival and metastatic pattern of pancreatic and periampullary cancer after adjuvant chemoradiation or observation: long-term results of EORTC trial 40891. Ann Surg 2007 2.48
6 POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. Cancer Res 2003 2.45
7 High-resolution array comparative genomic hybridization of chromosome arm 8q: evaluation of genetic progression markers for prostate cancer. Genes Chromosomes Cancer 2005 2.25
8 Cure of Barrett's carcinoma by ifosfamide chemotherapy. Eur J Gastroenterol Hepatol 2002 1.92
9 Whole genome scanning identifies genotypes associated with recurrence and metastasis in prostate tumors. Hum Mol Genet 2004 1.80
10 Outcome of surgical treatment for early adenocarcinoma of the esophagus or gastro-esophageal junction. Virchows Arch 2005 1.74
11 Truncated ETV1, fused to novel tissue-specific genes, and full-length ETV1 in prostate cancer. Cancer Res 2008 1.68
12 Aneuploidy and overexpression of Ki67 and p53 as markers for neoplastic progression in Barrett's esophagus: a case-control study. Am J Gastroenterol 2009 1.60
13 The use of clinical, histologic, and serologic parameters to predict the intragastric extent of intestinal metaplasia: a recommendation for routine practice. Gastrointest Endosc 2009 1.56
14 Bile acid-stimulated expression of the farnesoid X receptor enhances the immune response in Barrett esophagus. Am J Gastroenterol 2008 1.51
15 The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis. Gastrointest Endosc 2010 1.46
16 Barrett's oesophageal adenocarcinoma encompasses tumour-initiating cells that do not express common cancer stem cell markers. J Pathol 2010 1.44
17 The sentinel node concept in adenocarcinomas of the distal esophagus and gastroesophageal junction. J Thorac Cardiovasc Surg 2009 1.39
18 The role of EXT1 in nonhereditary osteochondroma: identification of homozygous deletions. J Natl Cancer Inst 2007 1.37
19 The molecular biology of esophageal adenocarcinoma. J Surg Oncol 2005 1.32
20 Mistaken identity of widely used esophageal adenocarcinoma cell line TE-7. Cancer Res 2007 1.27
21 Integration of high-resolution array comparative genomic hybridization analysis of chromosome 16q with expression array data refines common regions of loss at 16q23-qter and identifies underlying candidate tumor suppressor genes in prostate cancer. Oncogene 2004 1.20
22 Narrow band imaging for the detection of gastric intestinal metaplasia and dysplasia during surveillance endoscopy. Dig Dis Sci 2010 1.07
23 Adjuvant 5-FU-based chemoradiotherapy for patients undergoing R-1/R-2 resections for pancreatic cancer. Dig Surg 2005 1.05
24 Biopsy strategies for endoscopic surveillance of pre-malignant gastric lesions. Helicobacter 2010 1.05
25 A back-to-back comparison of white light video endoscopy with autofluorescence endoscopy for adenoma detection in high-risk subjects. Gut 2010 1.02
26 Molecular evaluation of ablative therapy of Barrett's oesophagus. J Pathol 2005 0.98
27 Adjuvant intra-arterial chemotherapy and radiotherapy versus surgery alone in resectable pancreatic and periampullary cancer: a prospective randomized controlled trial. Ann Surg 2008 0.98
28 Barrett's oesophagus is characterized by a predominantly humoral inflammatory response. J Pathol 2005 0.97
29 Lymph node retrieval during esophagectomy with and without neoadjuvant chemoradiotherapy: prognostic and therapeutic impact on survival. Ann Surg 2014 0.95
30 Fluorodeoxyglucose positron emission tomography for evaluating early response during neoadjuvant chemoradiotherapy in patients with potentially curable esophageal cancer. Ann Surg 2011 0.93
31 Inter-observer variation in the histological diagnosis of polyps in colorectal cancer screening. Histopathology 2011 0.93
32 Functional single-nucleotide polymorphism of epidermal growth factor is associated with the development of Barrett's esophagus and esophageal adenocarcinoma. J Hum Genet 2011 0.90
33 Aneuploidy and high expression of p53 and Ki67 is associated with neoplastic progression in Barrett esophagus. Cancer Biomark 2008 0.90
34 Construction and application of a full-coverage, high-resolution, human chromosome 8q genomic microarray for comparative genomic hybridization. Cytometry A 2005 0.88
35 Local application of tacrolimus in distal colitis: feasible and safe. Inflamm Bowel Dis 2009 0.88
36 Chromosomal and microsatellite instability of adenocarcinomas and dysplastic lesions (DALM) in ulcerative colitis. Diagn Mol Pathol 2006 0.87
37 Angiogenesis: a prognostic determinant in pancreatic cancer? Eur J Cancer 2011 0.86
38 Molecular genetic evidence of an association between nasal polyposis and the Peutz-Jeghers syndrome. Ann Intern Med 2002 0.85
39 Genomic analysis of Barrett's esophagus after ablative therapy: persistence of genetic alterations at tumor suppressor loci. Int J Cancer 2006 0.83
40 Nasal polyposis in Peutz-Jeghers syndrome: a distinct histopathological and molecular genetic entity. J Clin Pathol 2006 0.83
41 Expression, localization and polymorphisms of the nuclear receptor PXR in Barrett's esophagus and esophageal adenocarcinoma. BMC Gastroenterol 2011 0.82
42 Biomarkers for risk stratification of neoplastic progression in Barrett esophagus. Cell Oncol 2007 0.82
43 Differential expression of the nuclear receptors farnesoid X receptor (FXR) and pregnane X receptor (PXR) for grading dysplasia in patients with Barrett's oesophagus. Histopathology 2011 0.81
44 Multiple forms of genetic instability within a 2-Mb chromosomal segment of 3q26.3-q27 are associated with development of esophageal adenocarcinoma. Genes Chromosomes Cancer 2006 0.81
45 Sporadic duodenal adenoma and the association with colorectal neoplasia: a case-control study. Am J Gastroenterol 2008 0.80
46 Allelic imbalance of 7q32.3-q36.1 during tumorigenesis in Barrett's esophagus. Cancer Res 2002 0.80
47 Timing of 5-aminolaevulinic acid-induced photodynamic therapy for the treatment of patients with Barrett's oesophagus. J Photochem Photobiol B 2002 0.80
48 Cyst-like schwannoma on the eyelid margin. J Craniofac Surg 2012 0.80
49 Biomarker-based prediction of inflammatory bowel disease-related colorectal cancer: a case-control study. Cell Oncol (Dordr) 2011 0.78
50 Differential expression and prognostic value of HMGA1 in pancreatic head and periampullary cancer. Eur J Cancer 2010 0.78
51 Serum levels of leptin as marker for patients at high risk of gastric cancer. Helicobacter 2009 0.78
52 Spectrum of genetic changes in gastro-esophageal cancer cell lines determined by an integrated molecular cytogenetic approach. Cancer Genet Cytogenet 2002 0.76
53 Cure of Barrett's carcinoma by ifosfamide chemotherapy. Eur J Gastroenterol Hepatol 2003 0.75
54 Allelic imbalance on distal 7q (7q36.1-q36.3) in gastric cardia and oesophageal (Barrett's) adenocarcinoma. Anticancer Res 2005 0.75
55 Bcl-2 associated anthanogen-1 (Bag-1) expression and prognostic value in pancreatic head and periampullary cancer. Eur J Cancer 2012 0.75
56 Array-based genomic analysis of screen-detected Gleason score 6 and 7 prostatic adenocarcinomas. Anticancer Res 2006 0.75
57 Lymph Node Yield in Colon Cancer: Individuals Can Make the Difference. Dig Surg 2015 0.75
58 Identification of a 7.1-mega base pairs minimal deletion at 14q31.1-32.11 in adenocarcinomas of the gastroesophageal junction. Hum Pathol 2006 0.75